Abstract:OBJECTIVE:To design shRNA targeted to human vascular endothelial growth factor (VEGF) and to evaluate the effect of VEGF. shRNA on expression of VEGF in human retinal pigment epithelium (RPE) cells in vitro.METHODS:Human RPE cells were isolated with enzyme-assisted microdissection. The cells were identified by immunohistochemical method with antibody to cytokeratin and S-100. Plasma DNA was identified via restriction enzyme EcoRI and SamI. shRNAs (P1, P2) specific for human VEGF were designed. DNA expression vector is pSilencer 4.1-CMV of Ambion company. P3 is negative control nonspecific shRNA. There are 5 groups. Group 1: VEGF in cultured human RPE exposed to 100 micromol/L CoCl2 30 h; Group 2: VEGF in cultured human RPE in normal culture medium; Group 3, 4, 5: VEGF in cultured human RPE exposed to 100 micromol/L CoCl2 30 h after P1, P2, P3 transfection, respectively. VEGF level in conditioned media was measured by Western blot.RESULTS:The cells in culture could be stained with both cytokeratin and S-100 antibodies. The length of two fragment was 3.3 kb and 1.6 kb, respectively, which indicated that the extraction and purification were successful. The expression of VEGF in RPE was increased significantly (P < 0. 001) in group 1 as compared with group 2. Hypoxia-induced upregulation of human VEGF is halted by siRNA application in vitro (P < 0. 001 and P < 0. 001 in group 3 and 4 compared with group 1, respectively). shRNAs targeted hVEGF effectively and specifically inhibited hypoxia-induced VEGF levels in human RPE. The level of VEGF was reduced 65.9% and 52.4% in groups 3 and 4, respectively. There was no difference between group 5 and 1 (P = 0. 147). There was no difference of beta-actin production in RPE cells among groups.CONCLUSIONS:Delivery of shRNA can be used in vitro to target specific RNAs of VEGF and to reduce the level of the specific protein product (VEGF) in the targeted cells (human RPE). This work established the basis for the using of RNA interference in studies of retinal biology and for the treatment of a variety of retinal angiogenic diseases, especially the choroidal neovascularization.

Establishment and identification of small hairpin interfering RNA eukaryotic expression vectors of human platelet-derived growth factor A

Construction and Identification of Lentiviral Vector-mediated RNA Interference of Epidermal Growth Factor Receptor

[Preparation of the High-Titer Retroviral Viruses for Transducting PDGF-A Gene].

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Effectively Inhibits Expression of Vascular Endothelial Growth Factor in Human Retinal Pigment Epithelium

Effect of different culture conditions on the expression of platelet-derived growth factor-A of cultured human retinal pigment epithelium

The Generation of Eukaryotic Expression Vector of ShRNA Specific for VEGF Receptors Flt-1 and KDR

[Construction and Identification of Recombinant Human Platelet-Derived Growth Factor-B Adenoviral Vector and Transfection into Periodontal Ligament Stem Cells].

Construction of the recombinant adenovirus mediated short hairpin RNA to silence Polo-like kinase 1 and its biomedical application

Construction of connective tissue growth factor recombinant interference vector lentiviral particle and its inhibitory effect on endogenous connective tissue growth factor expression in retinal vascular endothelial cells

Construction and Identification of Lentiviral Vector of Sirna Specific for CTGF

Construction and Identification of Recombinant Adenovirus Vectors Expressing GFP and Human Vascular Endothelial Growth Factor Short Hairpin RNA

Construction and Expression of Eukaryotic Expression Plasmids of Shrna Targeting the PPARγ Gene

Construction and Assessment of Short-Hairpin Rna Eukaryotic Expression Vector Targeting Tgf-Beta 1 Labeled by Gfp

[Inhibition of VEGF Expression by Plasmid-Based RNA Interference in the Retinoblastoma Cells].

Construction of Eukaryotic Expression Plasmid of Human Platelet-Derived Growth Factor-B

Construction and Identification of Lentiviral Vector-mediated RNA Interference of VEGF Gene

Construction and identification of yeast expression vectors containing human platelet-derived growth factor B-chain gene]

Short Hairpin RNA Targeting Vascular Endothelial Growth Factor Inhibits Expression of Vascular Endothelial Cell in Human GBC-SD Cells

Inhibition of Vascular Endothelial Growth Factor A Expression in Mouse Granulosa Cells by Lentivector-Mediated RNAi.

Construction of Eukaryotic Expression Plasmid Expressing Shrna Targeting VEGF and NGF

Inhibition of Lentivirus-Tgfβ-r2 Shrna on the Expression of TGFβ-R2 in Human Lens Epithelial Cells